Skip to main content
Report this ad

See also:

Jessica Eye says her UFC fight with Alexis Davis is still on as planned

Sarah Kaufman says 'almost everyone' thinks she beat Jessica Eye
Photo by Christian Petersen/Getty Images

According to a Feb. 3 report from MMA Fighting, UFC bantamweight contender Jessica "Evil" Eye has opened up about her UFC 166 victory over Canadian standout Sarah Kaufman being changed to a "no decision."

Eye, 27, says she isn't suspended and that she'll be fighting Alexis Davis at UFC 170, as had been originally scheduled.

The Texas Department of Licensing and Regulation Commission has suspended Eye for one full year and fined her $1,875 for failing a post-fight drug test for an unnamed substance, but the Ohio native plans to fight the decision.

Eye also took to Twitter to let fight fans know that her upcoming UFC fight against Alexis Davis is still on.

"I PROMISE YOU I AM NOT SUSPEND and WILL BE FIGHTING FEB 22 as scheduled !! @UFC don't believe everything you read online !" Eye tweeted.

Eye vs Davis is widely viewed as a No. 1 contender bout to determine who is next to fight for the UFC bantamweight strap.

With Cat Zingano still mourning the loss of her husband and Julianna Pena sidelined with a knee injury, Eye and Davis are likely next in line for a title shot. Whoever wins their fight will likely take on the winner of the UFC 170 main event between Ronda Rousey vs Sara McMann.

UFC 170 goes down Feb. 22 at the Mandalay Bay Events Center in Las Vegas, Nev.

Sarah Kaufman also had a lot to say about UFC 166 being changed to a "no decision," as she immediately called for a rematch with Eye.

"I've been pushing for a @jessicaevileye rematch since the decision and now that it's overturned we HAVE to get at each other #ufc," Kaufman tweeted.

The Texas Department of Licensing and Regulation Commission has since explained its ruling on Eye is probationary, which would allow her to compete at UFC 170 against Davis.

No word yet on what substance Eye allegedly tested positive for.

Report this ad